doi: 10.1172/JCI116186 59 LynnFCThompsonSAPospisilikJAEhsesJAHinkeSAPamirNet al
Ozempic Litigation: Everything You Need to Know About Lawsuits Against Novo Nordisk Ozempic is a medication prescribed to individuals with type 2 diabetes that has recently gained popularity for weight loss purposes
Tesamorelin vs Ipamorelin: Side-by-Side Comparison Tesamorelin has a stronger evidence base, particularly in translational research
Tirzepatide may produce slightly faster initial results at equivalent time points
Thyroid hormone levels, particularly T3, decrease during prolonged caloric restriction
Quick recap of why this matters on semaglutide Semaglutide, available in India as Obeda (Dr Reddys Laboratories, launched March 2026) and as Ozempic, is a GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives significant weight loss